Christopher L. Lotz serves as Executive at Qualigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher L. Lotz has executed 2 insider transactions totaling $5.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 16, 2021 involved purchasing 2,700 shares valued at $5.0K.
Christopher L. Lotz currently holds 12,541 shares of Qualigen Therapeutics, Inc. (QLGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher L. Lotz has been a net buyer of QLGN stock. They have purchased $5.0K and sold $0 worth of shares.
Christopher L. Lotz's most recent insider trade was on Apr 16, 2021, when they purchased 2,700 shares at $1.86 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |